Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Pierre Fabre Médicament
Woman and Man Max 99 years
Pierre Fabre Médicament
Update Il y a 4 ans
EFFICACY AND SAFETY STUDY OF THE ANTIHISTAMINE V0114CP 2.5MG IN THE TREATMENT OF PERENNIAL ALLERGIC RHINITIS. RANDOMISED, DOUBLE-BLIND, THREE ARM PARALLEL GROUP STUDY INCLUDING PLACEBO AND ACTIVE CONTROL ARM (LEVOCETIRIZINE 5 MG)
- to demonstrate the efficacy of a 6-week treatment by the antihistamine V0114CP 2.5 mg versus placebo in reducing symptoms during perennial allergic rhinitis.
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Pierre Fabre Médicament
Update Il y a 4 ans
Post-operative care by chlorhexidine mouthwash after periodontal surgery. Randomised, parallel groups; blind study, DC071BB versus placebo, in patients presenting with periodontal surgery with suture
To assess the efficacy of DC071BB08b mouthwash for controlling the evolution of plaque index in peri-surgical area during the post-operative period.
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Pierre Fabre Médicament
Update Il y a 4 ans
Analyse du profil sensoriel du sirop antihistaminique Primalan®, versus un sirop antihistaminique de reference : Aerius®
Réaliser le profil sensoriel comparatif de deux sirops antihistaminiques, Primalan® et Aerius®, par la description de leurs caractéristiques sensorielles avant et pendant la mise en bouche, et après a...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Pierre Fabre Médicament
Update Il y a 4 ans
Study of efficacy and safety of V0305 solution in children suffering from Iron Deficiency Anaemia (IDA)
To document the effect of V0305 administered during 3 months (princeps period) on the blood haemoglobin level in children with IDA .
Country
None
organs
None
Specialty
None
unknown
More information
Woman Max 99 years
Pierre Fabre Médicament
Update Il y a 4 ans
Randomised phase II study of the combination of oral vinorelbine with capecitabine versus gemcitabine in combination with paclitaxel versus gemcitabine in combination with docetaxel as first line chemotherapy in patients with metastatic breast cancer
To evaluate simultaneously the Overall Response Rates (ORR) of oral vinorelbine in combination with capecitabine, gemcitabine in combination with paclitaxel and gemcitabine in combination with docetax...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Pierre Fabre Médicament
Update Il y a 4 ans
Etude chez le sujet volontaire sain de l’effet de carbolevure versus placebo sur la fermentation intestinale induite par l’ingestion de lactulose
L'objectif principal de cet essai est d’évaluer l’effet de Carbolevure® sur la fermentation intestinale induite par l’ingestion de lactulose par la mesure du taux d’hydrogène expiré.
Country
None
organs
None
Specialty
None
unknown
More information
Man Max 99 years
Pierre Fabre Médicament
Update Il y a 4 ans
Evaluation of erectyle disfonction in patients suffering from testosterone deficiency, before and after tretament by Testopatch
To evaluate the effect of testosterone supplementation with Testopatch® in hypogonadal patients complaining of erectile dysfunction.
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Pierre Fabre Médicament
Update Il y a 4 ans
Evaluation du pouvoir bactériostatique de la préparation V0079CR CETAVLON sur la flore cutanée au niveau des mains. Etude preuve de concept
Evaluer le pouvoir bactériostatique de la préparation CETAVLON sur la flore cutanée au niveau des mains par des mesures microbiologiques (dénombrement et identification).
Country
None
organs
None
Specialty
None
unknown
More information
Woman Max 99 years
Pierre Fabre Médicament
Update Il y a 4 ans
Randomised phase II study of the combination of oral vinorelbine with capecitabine versus a sequential regimen of oral vinorelbine and capecitabine versus the combination of docetaxel and capecitabine in patients with metastatic breast cancer previously treated with anthracyclines
To evaluate simultaneously the response rate of the combination of oral vinorelbine with capecitabine, a sequential regimen of oral vinorelbine and capecitabine, and the combination of docetaxel and ...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Pierre Fabre Médicament - IRPF
Update Il y a 4 ans
Exploratory study of the efficacy and safety of flexible doses of Milnacipran and Venlafaxine administered in out patients with Major Depressive Disorder
- To assess the percentage of responders in both treatment groups, Milnacipran or Venlafaxine administered up to 200 mg/day in flexible doses, during a treatment period of 8 weeks including up-titrati...
Country
None
organs
None
Specialty
None
unknown
More information
1
2
3
Next